# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-019634
Filing Date
2021-04-20
Accepted
2021-04-20 16:14:13
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | rcus-defa14a_20210603.htm | DEFA14A | 20719
2 | GRAPHIC | g1michufdpy5000001.jpg | GRAPHIC | 490443
3 | GRAPHIC | g1michufdpy5000002.jpg | GRAPHIC | 394061
| Complete submission text file | 0001564590-21-019634.txt |  | 1239380

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38419 | Film No.: 21837987
SIC: 2834 Pharmaceutical Preparations